Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ALB US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Albemarle Corp(ALB US)

$94.85-1.121.17%Ext:$94.67-0.180.19%(Pre-Market · 13:11:35 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ALB US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Albemarle Corp(ALB US)

$94.85-1.121.17%Ext:$94.67-0.180.19%(Pre-Market · 13:11:35 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Albemarle Corp — Company Profile

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Sector
Materials
Industry
Chemicals
Exchange
UN
CEO
Jerry Kent Jr.
Headquarters
Charlotte, NC, US
IPO Date
Feb 22, 1994
Employees
7,800
Website
www.albemarle.com

Key Metrics

Price
$104.59
Market Cap
$12.33B
Revenue (TTM)
$1.43B
Net Income (TTM)
$319.09M
EPS (TTM)
2.35

Albemarle Corp — Company Profile

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Sector
Materials
Industry
Chemicals
Exchange
UN
CEO
Jerry Kent Jr.
Headquarters
Charlotte, NC, US
IPO Date
Feb 22, 1994
Employees
7,800
Website
www.albemarle.com

Key Metrics

Price
$104.59
Market Cap
$12.33B
Revenue (TTM)
$1.43B
Net Income (TTM)
$319.09M
EPS (TTM)
2.35
P/E (TTM)
-52.97
P/B (TTM)
1.25
Dividend Yield
91.83%
ROE (TTM)
3.24%
ROA (TTM)
2.11%
Operating Margin
16.34%
Beta
1.48

Dividends

Last Dividend
$0.41
Last Yield
0.92%

Summary

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Website
www.albemarle.com
Location
Charlotte, NC, US
Phone980 299 5700
Employees7,800
CEOJerry Kent Jr.
Sector
Materials
Industry
Chemicals
IPO DateFeb 22, 1994

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(2K)

Expand
  • Form 4Sheorey Neal Ravi10 Nov
  • SC 13GALBEMARLE CORP10 Nov
  • 10-QQ3ended 30 Sept 20264 Nov
  • 8-KResults of Operations and Financial Condition4 Nov
  • 8-KEntry into a Material Definitive Agreement30 Oct
  • SC 13GALBEMARLE CORP28 Oct
  • Form 4Wolff Alejandro Daniel2 Oct
  • SDSD23 Sep
  • Form 4Norris Eric16 Sep
  • Form 4Mummert Mark Richard16 Sep
  • Form 4Gagarinas Autumn M.16 Sep
  • Form 4Hood Max3 Sep
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers3 Sep
  • Form 3Hood Max25 Aug
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers21 Aug
  • 10-QQ2ended 30 Jun 20265 Aug
  • 8-KResults of Operations and Financial Condition5 Aug
  • Form 4DESALLES BARTOLOMEO EDUARDO23 Jul
  • Form 3DESALLES BARTOLOMEO EDUARDO23 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers23 Jul

News

  • Is Albemarle (ALB) a Buy as Wall Street Analysts Look Optimistic?11 Nov
  • Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It10 Nov
  • Albemarle Corporation $ALB Shares Bought by AEGON ASSET MANAGEMENT UK Plc10 Nov
  • 6,425 Albemarle Corporation $ALB Shares Bought by CenterBook Partners LP9 Nov
  • Albemarle Q3 Earnings Call Highlights Cost Discipline and Lithium Demand6 Nov
  • What Albemarle (ALB) Said on Its Q3 Earnings Call6 Nov
  • Albemarle Corporation (ALB) Q3 2026 Earnings Call Transcript5 Nov
  • ALB Q3 Earnings Beat Estimates on Higher Lithium Pricing5 Nov
  • Albemarle (ALB) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates4 Nov
  • Albemarle (ALB) Tops Q3 Earnings and Revenue Estimates4 Nov
  • Albemarle Reports Third Quarter 2026 Results4 Nov
  • ALB to Report Q3 Earnings: What's in the Offing for the Stock?2 Nov
  • Here's Why Albemarle (ALB) is a Strong Growth Stock30 Oct
  • Albemarle (ALB) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates30 Oct
  • Albemarle (ALB) Dips More Than Broader Market: What You Should Know29 Oct
  • Do Options Traders Know Something About Albemarle Stock We Don't?29 Oct
  • Best Dividend Aristocrats For November 202629 Oct
  • Albemarle (ALB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release28 Oct
  • Here's Why Albemarle (ALB) is a Strong Value Stock27 Oct
  • Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know27 Oct

Mentions in Filings

  • … tered in Charlottesville, Virginia, is the bank holding company for Virginia National Bank. The Bank has seven banking offices throughout Fauquier and Prince William counties, four banking offices in Charlottesville and <strong>Albemarle</strong> County (including one limited-service banking facility), and banking offices in Winchester and Richmond, Virginia. The Bank offers a full range of banking and related financial services to meet the needs of individuals, …
    Virginia National Bankshares CorpAlbemarle Corp·EX-99.1 - 8-K - Other Events·Q4 26·10 Nov
  • … uptake following nasal foralumab PRE FORALUMAB POST FORALUMAB PRE FORALUMAB POST FORALUMAB Marked reduction in Cerebellar white matter uptake following nasal foralumab Questions Nasdaq: TLSA US Headquarters (Boston) Tiziana Life Sciences Ltd. 535 Boylston Street, Floor 8 Boston, MA 02116 UK Headquarters (London) Tiziana Life Sciences plc 35a <strong>Albemarle</strong> Street London W1S 4JE Investors: +44 (0)207 495 2379 [email protected] Nasdaq: TLSA
    Tiziana Life Sciences LtdAlbemarle Corp·EX-99.2 - 6-K - TIZIANA LIFE SCIENCES LTD PRESENTATION, DATED NOVEMBER 9, 2026·Q4 26·9 Nov
  • … 8-26 - - 74.4 1.2% 74.4 1.2% Yes 18.9 1.1% Moblan Elevra Lithium (60%); IQ (40%) Québec, Canada Non-Operating JORC Company Filing (2026 Annual Report) 28-08-26 6.3 1.5% 101.4 1.2% 107.7 1.2% Yes 13.3 1.1% Kings Mountain <strong>Albemarle</strong> North Carolina, U.S. Non-Operating S-K 1300 Albemarle 10-K (2025) 31-12-25 - - 63.9 1.4% 63.9 1.4% No 27.6 1.2% Galaxy Rio Tinto Québec, Canada Non-Operating JORC Company Filing (Initial reporting of lithium Mineral Reso …
    Elevra Lithium LtdAlbemarle Corp·EX-99.3 - 6-K - EXHIBIT 99.3·Q2 27·6 Nov
  • … n his career, he served as Chief of Staff for Political Military Affairs at the U.S. State Department and worked in corporate strategy and management consulting. Mr. O’Connell currently serves as a board member of <strong>Albemarle Corporation</strong>, VolvoCars AB and Clarios International Inc. **Family Relationships** There are no family relationships between any of the combined company’s expected executive officers or directors. **Corporate Governance** * …
    DANA IncAlbemarle Corp·DEFM14A - Definitive proxy statement (merger)·Q4 26·5 Nov
  • … n his career, he served as Chief of Staff for Political Military Affairs at the U.S. State Department and worked in corporate strategy and management consulting. Mr. O’Connell currently serves as a board member of <strong>Albemarle Corporation</strong>, VolvoCars AB and Clarios International Inc. **Family Relationships** There are no family relationships between any of the combined company’s expected executive officers or directors. **Corporate Governance** * …
    Mobility (USA) CorpAlbemarle Corp·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·5 Nov
  • … ain lithium mineral producers were Australia, China and Zimbabwe. Other relevant regions for lithium production were Brazil, Nigeria and Canada. Elevra competes against several major lithium producers, including: <strong>Albemarle Corporation</strong>, Sigma Lithium Corporation, Sociedad Química y Minera de Chile S.A., Tianqi Lithium Corporation, Ganfeng Lithium Co., Ltd., Mineral Resources Limited, Pilbara Minerals Limited, Rio Tinto (following its acquisition …
    Elevra Lithium LtdAlbemarle Corp·20-F - Annual report (foreign private issuer) FY 2026·FY26·2 Nov

Key Stats

Trading

Px/Chg 1D$104.59 / -0.42%
Prev Close$132.16
% of 52Wk H57.14%
Avg Volume2.20M
Beta1.48
Mkt Cap12.33B
FD Mkt Cap14.89B

Float

Shrs Out/Float117.93M / 117.54M
Short Float0.09%
Days to Cover3.77
Stock Repurchased$3.94M

Current Valuation

EV15.62B
EV/EBITDA22.92
EV/Sales2.84
P/B1.25
P/S2.24
FCF Yield2.01%
ROE3.24%
ROA2.11%
Current Ratio2.07

Dividend

Cash$0.41
Yield91.83%
Yield (TTM)91.83%

Estimates

P/E-52.97
Est P/E0.00
Est EPS1.19
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Apr '24Apr '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-1.277.558.97-5.92-55.3638.40
Price / Sales6.032.771.471.3016.068.58
Price / Book Value1.682.541.500.702.411.24
Price / Free Cash Flow31.0431.43-17.05-7.0498.3749.49
ENTERPRISE VALUE METRICS
Enterprise Value18,921.322,334.117,757.911,884.227,092.415,537.9
Enterprise Value / Sales7.393.051.852.2118.9710.88
Enterprise Value / EBITDA-275.037.9726.46-263.70-1,180.8034.91
Enterprise Value / EBIT-5.448.9373.65-18.69-145.1554.08

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue11.5%3,328.07,320.19,617.25,377.55,142.7
Gross Income-9.7%1,008.53,085.61,201.060.2671.6
EBITDA-8.1%786.72,802.3671.1-45.1559.9
EBIT—532.72,501.5241.1-636.0-100.7
Net Income—123.72,689.81,573.5-1,179.4-510.6
EPS (Diluted)—1.0622.8413.36-11.20-5.75
BALANCE SHEET
Cash & ST Inv38.5%439.31,499.1889.91,192.21,618.0
Total Assets10.5%10,974.115,456.518,270.716,609.616,374.2
Total Liabilities6.3%5,168.57,265.78,605.66,410.06,592.8
Total Shareholder Equity14.1%5,625.37,982.69,412.29,961.59,533.4
CASH FLOW
Net Operating Cash Flow38.9%344.31,907.81,326.6687.91,282.3
Cap Ex-11.3%-953.7-1,261.6-2,154.5-1,680.5-589.8
Free Cash Flow—-609.4646.2-828.0-992.7692.5

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)93.88
Basic Shares117.93
Market Cap11,071.7
Diluted Shares118.54
Fully Diluted Shares Outstanding118.54
Fully Diluted Market Cap11,128.9
+Consolidated Debt1,881.4
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-1,846.0
−Short-term Investments-
+Total Preferred2,235.1
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest278.5
+Pension Liabilities—
Enterprise Value13,620.6

Segment data

Revenue

by Products and services

  • Energy Storage53%
  • Specialties27%
  • Ketjen21%

Revenue

by Geography

  • United States100%

Related companies

NIKE, Inc.

NKE US

Ppg Industries Inc

PPG US

Dow Inc.

DOW US

DuPont de Nemours, Inc.

DD US

Rpm International Inc/de/

RPM US

Deckers Outdoor Corp

DECK US

On Holding AG

ONON US

Advanced Drainage Systems, Inc.

WMS US

Eastman Chemical Co

EMN US

Axalta Coating Systems Ltd.

AXTA US

Hexcel Corp /DE/

HXL US

Crocs, Inc.

CROX US

P/E (TTM)
-52.97
P/B (TTM)
1.25
Dividend Yield
91.83%
ROE (TTM)
3.24%
ROA (TTM)
2.11%
Operating Margin
16.34%
Beta
1.48

Dividends

Last Dividend
$0.41
Last Yield
0.92%

Summary

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Website
www.albemarle.com
Location
Charlotte, NC, US
Phone980 299 5700
Employees7,800
CEOJerry Kent Jr.
Sector
Materials
Industry
Chemicals
IPO DateFeb 22, 1994

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(2K)

Expand
  • Form 4Sheorey Neal Ravi10 Nov
  • SC 13GALBEMARLE CORP10 Nov
  • 10-QQ3ended 30 Sept 20264 Nov
  • 8-KResults of Operations and Financial Condition4 Nov
  • 8-KEntry into a Material Definitive Agreement30 Oct
  • SC 13GALBEMARLE CORP28 Oct
  • Form 4Wolff Alejandro Daniel2 Oct
  • SDSD23 Sep
  • Form 4Norris Eric16 Sep
  • Form 4Mummert Mark Richard16 Sep
  • Form 4Gagarinas Autumn M.16 Sep
  • Form 4Hood Max3 Sep
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers3 Sep
  • Form 3Hood Max25 Aug
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers21 Aug
  • 10-QQ2ended 30 Jun 20265 Aug
  • 8-KResults of Operations and Financial Condition5 Aug
  • Form 4DESALLES BARTOLOMEO EDUARDO23 Jul
  • Form 3DESALLES BARTOLOMEO EDUARDO23 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers23 Jul

News

  • Is Albemarle (ALB) a Buy as Wall Street Analysts Look Optimistic?11 Nov
  • Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It10 Nov
  • Albemarle Corporation $ALB Shares Bought by AEGON ASSET MANAGEMENT UK Plc10 Nov
  • 6,425 Albemarle Corporation $ALB Shares Bought by CenterBook Partners LP9 Nov
  • Albemarle Q3 Earnings Call Highlights Cost Discipline and Lithium Demand6 Nov
  • What Albemarle (ALB) Said on Its Q3 Earnings Call6 Nov
  • Albemarle Corporation (ALB) Q3 2026 Earnings Call Transcript5 Nov
  • ALB Q3 Earnings Beat Estimates on Higher Lithium Pricing5 Nov
  • Albemarle (ALB) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates4 Nov
  • Albemarle (ALB) Tops Q3 Earnings and Revenue Estimates4 Nov
  • Albemarle Reports Third Quarter 2026 Results4 Nov
  • ALB to Report Q3 Earnings: What's in the Offing for the Stock?2 Nov
  • Here's Why Albemarle (ALB) is a Strong Growth Stock30 Oct
  • Albemarle (ALB) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates30 Oct
  • Albemarle (ALB) Dips More Than Broader Market: What You Should Know29 Oct
  • Do Options Traders Know Something About Albemarle Stock We Don't?29 Oct
  • Best Dividend Aristocrats For November 202629 Oct
  • Albemarle (ALB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release28 Oct
  • Here's Why Albemarle (ALB) is a Strong Value Stock27 Oct
  • Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know27 Oct

Mentions in Filings

  • … tered in Charlottesville, Virginia, is the bank holding company for Virginia National Bank. The Bank has seven banking offices throughout Fauquier and Prince William counties, four banking offices in Charlottesville and <strong>Albemarle</strong> County (including one limited-service banking facility), and banking offices in Winchester and Richmond, Virginia. The Bank offers a full range of banking and related financial services to meet the needs of individuals, …
    Virginia National Bankshares CorpAlbemarle Corp·EX-99.1 - 8-K - Other Events·Q4 26·10 Nov
  • … uptake following nasal foralumab PRE FORALUMAB POST FORALUMAB PRE FORALUMAB POST FORALUMAB Marked reduction in Cerebellar white matter uptake following nasal foralumab Questions Nasdaq: TLSA US Headquarters (Boston) Tiziana Life Sciences Ltd. 535 Boylston Street, Floor 8 Boston, MA 02116 UK Headquarters (London) Tiziana Life Sciences plc 35a <strong>Albemarle</strong> Street London W1S 4JE Investors: +44 (0)207 495 2379 [email protected] Nasdaq: TLSA
    Tiziana Life Sciences LtdAlbemarle Corp·EX-99.2 - 6-K - TIZIANA LIFE SCIENCES LTD PRESENTATION, DATED NOVEMBER 9, 2026·Q4 26·9 Nov
  • … 8-26 - - 74.4 1.2% 74.4 1.2% Yes 18.9 1.1% Moblan Elevra Lithium (60%); IQ (40%) Québec, Canada Non-Operating JORC Company Filing (2026 Annual Report) 28-08-26 6.3 1.5% 101.4 1.2% 107.7 1.2% Yes 13.3 1.1% Kings Mountain <strong>Albemarle</strong> North Carolina, U.S. Non-Operating S-K 1300 Albemarle 10-K (2025) 31-12-25 - - 63.9 1.4% 63.9 1.4% No 27.6 1.2% Galaxy Rio Tinto Québec, Canada Non-Operating JORC Company Filing (Initial reporting of lithium Mineral Reso …
    Elevra Lithium LtdAlbemarle Corp·EX-99.3 - 6-K - EXHIBIT 99.3·Q2 27·6 Nov
  • … n his career, he served as Chief of Staff for Political Military Affairs at the U.S. State Department and worked in corporate strategy and management consulting. Mr. O’Connell currently serves as a board member of <strong>Albemarle Corporation</strong>, VolvoCars AB and Clarios International Inc. **Family Relationships** There are no family relationships between any of the combined company’s expected executive officers or directors. **Corporate Governance** * …
    DANA IncAlbemarle Corp·DEFM14A - Definitive proxy statement (merger)·Q4 26·5 Nov
  • … n his career, he served as Chief of Staff for Political Military Affairs at the U.S. State Department and worked in corporate strategy and management consulting. Mr. O’Connell currently serves as a board member of <strong>Albemarle Corporation</strong>, VolvoCars AB and Clarios International Inc. **Family Relationships** There are no family relationships between any of the combined company’s expected executive officers or directors. **Corporate Governance** * …
    Mobility (USA) CorpAlbemarle Corp·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·5 Nov
  • … ain lithium mineral producers were Australia, China and Zimbabwe. Other relevant regions for lithium production were Brazil, Nigeria and Canada. Elevra competes against several major lithium producers, including: <strong>Albemarle Corporation</strong>, Sigma Lithium Corporation, Sociedad Química y Minera de Chile S.A., Tianqi Lithium Corporation, Ganfeng Lithium Co., Ltd., Mineral Resources Limited, Pilbara Minerals Limited, Rio Tinto (following its acquisition …
    Elevra Lithium LtdAlbemarle Corp·20-F - Annual report (foreign private issuer) FY 2026·FY26·2 Nov

Key Stats

Trading

Px/Chg 1D$104.59 / -0.42%
Prev Close$132.16
% of 52Wk H57.14%
Avg Volume2.20M
Beta1.48
Mkt Cap12.33B
FD Mkt Cap14.89B

Float

Shrs Out/Float117.93M / 117.54M
Short Float0.09%
Days to Cover3.77
Stock Repurchased$3.94M

Current Valuation

EV15.62B
EV/EBITDA22.92
EV/Sales2.84
P/B1.25
P/S2.24
FCF Yield2.01%
ROE3.24%
ROA2.11%
Current Ratio2.07

Dividend

Cash$0.41
Yield91.83%
Yield (TTM)91.83%

Estimates

P/E-52.97
Est P/E0.00
Est EPS1.19
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Apr '24Apr '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-1.277.558.97-5.92-55.3638.40
Price / Sales6.032.771.471.3016.068.58
Price / Book Value1.682.541.500.702.411.24
Price / Free Cash Flow31.0431.43-17.05-7.0498.3749.49
ENTERPRISE VALUE METRICS
Enterprise Value18,921.322,334.117,757.911,884.227,092.415,537.9
Enterprise Value / Sales7.393.051.852.2118.9710.88
Enterprise Value / EBITDA-275.037.9726.46-263.70-1,180.8034.91
Enterprise Value / EBIT-5.448.9373.65-18.69-145.1554.08

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue11.5%3,328.07,320.19,617.25,377.55,142.7
Gross Income-9.7%1,008.53,085.61,201.060.2671.6
EBITDA-8.1%786.72,802.3671.1-45.1559.9
EBIT—532.72,501.5241.1-636.0-100.7
Net Income—123.72,689.81,573.5-1,179.4-510.6
EPS (Diluted)—1.0622.8413.36-11.20-5.75
BALANCE SHEET
Cash & ST Inv38.5%439.31,499.1889.91,192.21,618.0
Total Assets10.5%10,974.115,456.518,270.716,609.616,374.2
Total Liabilities6.3%5,168.57,265.78,605.66,410.06,592.8
Total Shareholder Equity14.1%5,625.37,982.69,412.29,961.59,533.4
CASH FLOW
Net Operating Cash Flow38.9%344.31,907.81,326.6687.91,282.3
Cap Ex-11.3%-953.7-1,261.6-2,154.5-1,680.5-589.8
Free Cash Flow—-609.4646.2-828.0-992.7692.5

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)93.88
Basic Shares117.93
Market Cap11,071.7
Diluted Shares118.54
Fully Diluted Shares Outstanding118.54
Fully Diluted Market Cap11,128.9
+Consolidated Debt1,881.4
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-1,846.0
−Short-term Investments-
+Total Preferred2,235.1
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest278.5
+Pension Liabilities—
Enterprise Value13,620.6

Segment data

Revenue

by Products and services

  • Energy Storage53%
  • Specialties27%
  • Ketjen21%

Revenue

by Geography

  • United States100%

Related companies

NIKE, Inc.

NKE US

Ppg Industries Inc

PPG US

Dow Inc.

DOW US

DuPont de Nemours, Inc.

DD US

Rpm International Inc/de/

RPM US

Deckers Outdoor Corp

DECK US

On Holding AG

ONON US

Advanced Drainage Systems, Inc.

WMS US

Eastman Chemical Co

EMN US

Axalta Coating Systems Ltd.

AXTA US

Hexcel Corp /DE/

HXL US

Crocs, Inc.

CROX US